Skip to content
Open access · OA via OpenAlex

Sirtuin 1 activation attenuates cardiac fibrosis in a rodent pressure overload model by modifying Smad2/3 transactivation

Antoinette Bugyei‐Twum, Christopher Ford, Robert Civitarese, Jessica Seegobin, Suzanne L. Advani, Jean‐François Desjardins, Golam Kabir, Yanling Zhang, Melissa Mitchell, Jennifer Switzer, Kerri Thai, V. Shen, Armin Abadeh, Krishna K. Singh, Filio Billia

Cardiovascular Research · 2018 · ▲ 95 citations

Abstract

Aims: Transforming growth factor β1 (TGF-β1) is a prosclerotic cytokine involved in cardiac remodelling leading to heart failure (HF). Acetylation/de-acetylation of specific lysine residues in Smad2/3 has been shown to regulate TGF-β signalling by altering its transcriptional activity. Recently, the lysine de-acetylase sirtuin 1 (SIRT1) has been shown to have a cardioprotective effect; however, SIRT1 expression and activity are paradoxically reduced in HF. Herein, we investigate whether pharmacological activation of SIRT1 would induce cardioprotection in a pressure overload model and assess the impact of SIRT1 activation on TGF-β signalling and the fibrotic response. Methods and results: Eight weeks old male C57BL/6 mice were randomized to undergo sham surgery or transverse aortic constriction (TAC) to induce pressure overload. Post-surgery, animals were further randomized to receive SRT1720 or vehicle treatment. Echocardiography, pressure-volume loops, and histological analysis revealed an impairment in cardiac function and deleterious left ventricular remodelling in TAC-operated animals that was improved with SRT1720 treatment. Genetic ablation and cell culture studies using a Smad-binding response element revealed SIRT1 to be a specific target of SRT1720 and identified Smad2/3 as a SIRT1 specific substrate. Conclusion: Overall, our data demonstrate that Smad2/3 is a specific SIRT1 target and suggests that pharmacological activation of SIRT1 may be a novel therapeutic strategy to prevent/reverse HF via modifying Smad activity.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.1093/cvr/cvy131
Canonical
link ↗
Fetched
2026-09-06 MST

Cite this

APA
Bugyei‐Twum, A., Ford, C., Civitarese, R., Seegobin, J., Advani, S.L., Desjardins, J., Kabir, G., Zhang, Y., Mitchell, M., Switzer, J., Thai, K., Shen, V., Abadeh, A., Singh, K.K., Billia, F., Advani, A., Gilbert, R.E., &amp; Connelly, K.A. (2018). Sirtuin 1 activation attenuates cardiac fibrosis in a rodent pressure overload model by modifying Smad2/3 transactivation. <em>Cardiovascular Research</em>. https://doi.org/10.1093/cvr/cvy131
Vancouver
Bugyei‐Twum A, Ford C, Civitarese R, Seegobin J, Advani SL, Desjardins J, et al. Sirtuin 1 activation attenuates cardiac fibrosis in a rodent pressure overload model by modifying Smad2/3 transactivation. Cardiovascular Research. 2018. doi:10.1093/cvr/cvy131.
BibTeX
@article{antoinette2018Sirtui, title = {Sirtuin 1 activation attenuates cardiac fibrosis in a rodent pressure overload model by modifying Smad2/3 transactivation}, author = {Antoinette Bugyei‐Twum and Christopher Ford and Robert Civitarese and Jessica Seegobin and Suzanne L. Advani and Jean‐François Desjardins and Golam Kabir and Yanling Zhang and Melissa Mitchell and Jennifer Switzer and Kerri Thai and V. Shen and Armin Abadeh and Krishna K. Singh and Filio Billia and Andrew Advani and Richard E. Gilbert and Kim A. Connelly}, journal = {Cardiovascular Research}, year = {2018}, doi = {10.1093/cvr/cvy131}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings